HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Supplementary figure and tables All Versions of this Article: 32/2/426    most recent 09031936.00126907v1 Alert me when this article is cited Alert me if a correction is posted Permissions Request Permissions Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Fabre, A. Articles by Crestani, B. Search for Related Content PubMed PubMed Citation Articles by Fabre, A. Articles by Crestani, B.

Modulation of bleomycin-induced lung fibrosis by serotonin receptor antagonists in mice

¹ Faculté de Médecine Denis Diderot, INSERM Unit 700, Université Paris 7, ² Service d'Anatomie Pathologique, ³ Service de Pneumologie, ⁴ Laboratoire de Biochimie A, Hôpital Bichat, Assistance Publique Hôpitaux de Paris, and ⁵ Service de Biochimie, Hôpital Lariboisière, Paris, France.

CORRESPONDENCE: B. Crestani, INSERM Unit 700, Faculté de Médecine Paris 7 Denis Diderot, 16 rue Henri Huchard, 75018 Paris, France. Fax: 33 140258818. E-mail: bruno.crestani{at}bch.aphp.fr

Keywords: Bleomycin, lung fibrosis, receptors, serotonin

Received: September 26, 2007
Accepted February 25, 2008

Serotonin (5-hydroxytryptamine; 5-HT) is known to increase proliferation and collagen synthesis by fibroblasts. Two receptor subtypes, 5-HT2A and 5-HT2B, have been shown to play the most important roles in the lung.

In the present study, the role of serotonin in lung fibrosis was investigated using the bleomycin mouse model.

Serotonin concentrations in lung homogenates increased significantly over the time course of bleomycin-induced fibrosis, with a maximum at day seven. The expression of serotonin receptors 5-HT2A and 5-HT2B increased in the lung after bleomycin treatment, as assessed by PCR, specific binding and immunohistochemistry. Blockage of 5-HT2A receptors by ketanserin and 5-HT2B receptors by SB215505 reduced bleomycin-induced lung fibrosis, as demonstrated by reduced lung collagen content and reduced procollagen 1 and procollagen 3 mRNA expression. Serotonin antagonists promoted an antifibrotic environment by decreasing the lung mRNA levels of transforming growth factor-β1, connective growth factor and plasminogen activator inhibitor-1 mRNA, but had minimal effects on lung inflammation as assessed by bronchoalveolar lavage cytology analysis. Interestingly, the 5-HT2B receptor was strongly expressed by fibroblasts in the fibroblastic foci in human idiopathic pulmonary fibrosis samples.

In conclusion, the present study showed involvement of serotonin in the pathophysiology of bleomycin-induced lung fibrosis in mice and identified it as a potential therapeutic target in lung fibrotic disorders.